RejuvaENHANCEMENT™ Procedure is like the PRP Priapus Shot on “Steroids.”

Regenerative Medicine is in it’s infancy and Simply Men’s Health, the leader in men’s sexual health, is a pioneer in the field of the field of regenerative medicine and men’s sexual health.  No longer are Viagra, penile injections or implants the only alternative for the millions of men suffering from erectile dysfunction.   Simply Men’s Health has revolutionized the field of men’s sexual health by introducing the ground-breaking RejuvaWave® Treatment that can actually reverse and CURE ED.  In addition, Simply Men’s Health has introduced the state-of-the-art  RejuvaEnhancement™ Procedure which promotes healing and regeneration and accelerates the effects of RejuvaWave® Treatment by adding either amniotic-derived live stems cells and growth factors or lyophilized amniotic/chorionic membane derived growth factors to the Priapus Shot PRP® .

What is Cryogenically-preserved Amniotic Allograft?

The RejuvaEnhancement™ Procedure utilizes a cryogenically preserved amniotic-derived allograft that contains LIVE Pluripotent Stem Cells, Growth Factors & Stem Cell Activators which promote tissue regeneration and potentiate the effects of the PRP  Priapus Shot®.

cutlivestem2This amniotic allograft is cryogenically-preserved tissue derived from human placentas during planned C-sections from consenting, screened donors. This amniotic allograft provides an extracellular matrix (ECM) needed for the infiltration, attachment and proliferation of cells required for the repair and regeneration of tissue. This amniotic allograft also is a rich source of over 75 growth factors, cytokines, collagen, and stem cell activators which call the body’s own stem cells. In addition this cryogenically-preserved allograft contains LIVE pluripotent stem cells and fibroblasts which enhance and potentiate the regenerative potential of the Priapus Shot PRP promoting tissue regeneration.

Tissue Safety: “100 year history” with no reported recipient rejections

The amniotic tissue is obtained through aseptic recovery technique during planned Caesarian section of full-term deliveries from healthy woman 18-35 years. The woman have been prescreened and tested according to the FDA and American Association of Tissue Banks (AATB) guidelines for infectious disease and have undergone extensive clinical risk assessment of their medical and social histories, and have undergone extensive blood and tissue tests for HIV, HTLV, CMV, Hepatitis A and B, Syphilis. Donor tissue is collected and minimally manipulated utilizing a proprietary process in accordance with the regulations of FDA 21 CFR Part 1271 and Section 361 of the Public Health Service Act.

This tissue allograft has a “100 year history” with no reported recipient rejections, since the amniotic tissue is immunoprivileged and does not express HLA type

The Power of Stem Cells

Stem cells have the remarkable potential to develop into many different cell types in the body during early life and growth. In addition, in many tissues they serve as a sort of internal repair system, dividing essentially without limit to replenish other cells as long as the person or animal is still alive. When a stem cell divides, each new cell has the potential either to remain a stem cell or become another type of cell with a more specialized function, such as a muscle cell, a red blood cell, or a brain cell.

Stem cells are distinguished from other cell types because they are unspecialized cells capable of renewing themselves through cell division sometimes after long periods of inactivity and can repair and replace worn out or damaged tissues.

Benefits of Live Stem Cells derived from High Quality Allograft Amniotic fluid and Membranes versus from your own Bone Marrow or Adipose Tissue:

  • High proliferative capacity and an abundant supply of live mesenchymal stem cells

  • Trilineage differentiation ability – ectoderm, mesoderm, and endoderm

  • Can differentiate into adipogenic, osteogenic, chondrogenic, and neural cells

  • Provokes little immune response when transplanted, cell rejection is not an issue and human leukocyte antigen (HLA) matching is not necessary

  • Immunomodulatory properties –

    • Cells do not pose risk for metastasis of tumor cells
    • Cells promote proteins that halt the cell cycle of cancer cells and promote tumor suppressing genes
    • Cells invoke the body’s immune system
  • Noninvasive procedures such as liposuction or bone marrow collection. Are more robust than other MSC from other sources such as fat. Range and level of specific cytokines that are
    different  from those expressed by adult mesenchymal stem cells

  • Have a stronger anti-inflammatory protective effect

  • Have less damage from reactive oxygen species (ROS)

  • Retain telomere at the highest possible length which protects them from premature loss of viability

  • Larger amount of different growth factors especially bFGF


What is Lyophilize Amniotic ECM ?



The RejuvaEnhancement™ Procedure can also use a lyophilized, human-placental derived extracellular matrix (ECM) that promotes bioactive healing and tissue regeneration, and reduces scar tissue formation.  The lyophilized amniotic tissue is derived from the chorionic membrane of the placenta and does not contain live cells.

This lyophilized chorionic-membrane derived tissue contains multiple essential growth factors including healing growth factor (EGF), transforming growth factor beta (TGF-b), fibroblast growth factor (FGF), and platelet derived growth factor (PDGF), extracellular matrix proteins, cytokines, and other specialty proteins present in placental tissue to enhance healing and regeneration. This amniotic tissue additive acts synergistically to enhance and potentiate the regenerative potential of PRP



Collection and Safety?

This amniotic tissue is obtained through the “Give the Gift of Healing” placenta donation program in which mothers who are delivering health babies by planned Caesarian section donate their placentas under strict control on quality from the time of tissue donation. The company developed and implemented a proprietary quality management system in compliance with both the Food and Drug Administration (FDA) and the American Association of Tissue Banks (AATB). To ensure patient safety, donor screening and testing is performed for each donor mother. Donor screening includes a review of both the donor’s medical and social history to ensure that the donor has not engaged in behaviors that place her at an increased risk for the transmission of infectious disease, and to ensure that the donor has not shown signs or symptoms of illnesses. In addition, each donor is tested for the infectious diseases: HIV, HTLV, Hepatitis B, Hepatitis C, Syphilis, and CMV. All allografts are terminally sterilized to enhance safety related to microbiolgical and viral transmission.

Amniotic tissues have been shown to have little to no HLA-A, B or C antigens and are not immunoreactive with the recipient.  Over One Million allografts have been distributed without adverse reactions.